Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: Martin Tauschmann Clear advanced filters
  • Jacobsen, Sherr et al. evaluate the utility of novel technologies in the treatment of type 1 diabetes. Their systematic review finds technologies such as continuous glucose monitoring, insulin pumps, and decision support tools improve important measures (e.g., HbA1c, time in range, quality of life) allowing precision-directed uptake of technology.

    • Laura M. Jacobsen
    • Jennifer L. Sherr
    • Paul W. Franks
    ResearchOpen Access
    Communications Medicine
    Volume: 3, P: 1-24
  • The incidence of type 1 diabetes mellitus (T1DM) is increasing. Novel treatment modalities, particularly from the field of diabetes technologies, have eased the burden of the disease. Here, the authors review established and novel diabetes technologies used in the management of patients with T1DM.

    • Martin Tauschmann
    • Roman Hovorka
    Reviews
    Nature Reviews Endocrinology
    Volume: 14, P: 464-475